Compare IVVD & NEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
New England Realty Associates Limited Partnership Depositary Receipts Evidencing Units of Limited Partnership
Current Price
| Metric | IVVD | NEN |
|---|---|---|
| Founded | 2020 | 1977 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Building operators |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 212.6M | 197.0M |
| IPO Year | 2021 | 1995 |
| Metric | IVVD | NEN |
|---|---|---|
| Price | $0.46 | $45.95 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $10.00 | N/A |
| AVG Volume (30 Days) | ★ 3.4M | 949.0 |
| Earning Date | 11-16-2026 | 03-12-2027 |
| Dividend Yield | N/A | ★ 3.48% |
| EPS Growth | ★ 79.02 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $53,426,000.00 | ★ $89,196,544.00 |
| Revenue This Year | $12.92 | N/A |
| Revenue Next Year | $44.18 | N/A |
| P/E Ratio | ★ N/A | $19.68 |
| Revenue Growth | ★ 110.47 | N/A |
| 52 Week Low | $0.49 | $43.00 |
| 52 Week High | $3.01 | $69.25 |
| Indicator | IVVD | NEN |
|---|---|---|
| Relative Strength Index (RSI) | 30.94 | 43.67 |
| Support Level | N/A | N/A |
| Resistance Level | $0.66 | $66.30 |
| Average True Range (ATR) | 0.05 | 0.58 |
| MACD | -0.01 | 0.05 |
| Stochastic Oscillator | 5.08 | 42.14 |
Invivyd Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of monoclonal antibody (mAb) therapies for the prevention and treatment of serious viral infectious diseases. Its lead product, PEMGARDA (pemivibart), received emergency use authorization from the U.S. FDA for the pre-exposure prevention of COVID-19 in certain immunocompromised individuals. The company is also developing next-generation antibody candidates, including VYD2311 for COVID-19 and VBY329 for RSV infections, while continuing research on additional antibodies targeting other viral diseases such as measles.
New England Realty Associates LP is engaged in the business of acquiring, developing, holding for investment, operating, and selling real estate. The Partnership owns and operates various residential apartments, condominium units, and commercial properties located in Massachusetts and New Hampshire. The company generates revenue from rental income from residential and commercial properties recognized over the term of the related lease. The long-term goals of the Partnership are to manage, rent, and improve its properties and to acquire additional properties with income and capital appreciation potential as suitable opportunities arise.